# OnCo record nct04478279 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04478279/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04478279", "NCT04478279" ;
  schema:name "A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors"@en ;
  schema:description "A phase 1/2 trial of Temozolomide in melanoma and prostate cancer, run by Sapience Therapeutics, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04478279/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04478279> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2020-07-01" ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/brain-tumours/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/temozolomide/> .